Squarepoint Ops LLC Macrogenics Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 37,170 shares of MGNX stock, worth $121,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,170

Holding current value

$121,174

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $5.55 $111,510 - $206,293	37,170 New	37,170 $122,000
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $132,658 - $216,503	28,714 Added 37.89%	104,493 $559,000
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $246,933 - $370,912	51,231 Added 208.7%	75,779 $543,000
Q4 2022 Feb 14, 2023	SELL	$3.34 - $6.98 $150,383 - $314,274	-45,025 Reduced 64.72%	24,548 $164,000
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $248,902 - $431,652	-82,692 Reduced 54.31%	69,573 $241,000
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $301,500 - $1.34 Million	134,000 Added 733.64%	152,265 $449,000
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $116,286 - $242,024	-14,321 Reduced 43.95%	18,265 $161,000
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $518,443 - $712,981	32,586 New	32,586 $523,000
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $1.56 Million - $2.71 Million	-75,998 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $452,018 - $790,259	23,803 Added 45.6%	75,998 $2.42 Million
Q4 2020 Feb 16, 2021	BUY	$19.41 - $26.0 $654,039 - $876,096	33,696 Added 182.15%	52,195 $1.19 Million
Q3 2020 Nov 16, 2020	SELL	$24.69 - $31.6 $1.14 Million - $1.46 Million	-46,099 Reduced 71.36%	18,499 $466,000
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $55,967 - $313,418	10,763 Added 19.99%	64,598 $1.8 Million
Q1 2020 May 15, 2020	BUY	$4.28 - $12.11 $19,683 - $55,693	4,599 Added 9.34%	53,835 $313,000
Q4 2019 Feb 14, 2020	SELL	$7.95 - $12.27 $861,883 - $1.33 Million	-108,413 Reduced 68.77%	49,236 $536,000
Q3 2019 Nov 14, 2019	BUY	$12.44 - $17.48 $475,730 - $668,470	38,242 Added 32.03%	157,649 $2.01 Million
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $9,605 - $13,048	662 Added 0.56%	119,407 $2.03 Million
Q1 2019 May 15, 2019	SELL	$11.11 - $25.6 $15,398 - $35,481	-1,386 Reduced 1.15%	118,745 $2.14 Million
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $895,902 - $1.63 Million	76,247 Added 173.75%	120,131 $1.53 Million
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $441,362 - $537,609	-22,916 Reduced 34.31%	43,884 $941,000
Q2 2018 Aug 14, 2018	BUY	$19.78 - $24.67 $551,862 - $688,293	27,900 Added 71.72%	66,800 $1.38 Million
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $734,821 - $1.26 Million	38,900 New	38,900 $979,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account